Senior Biopharmaceutical Representative Rare Diseases
Amgen
Senior Biopharmaceutical Representative Rare Diseases
Amgen
Makes biotech medicines for serious illnesses
Als führendes, international tätiges Biotechnologieunternehmen mit der Mission, Patientinnen und Patienten zu helfen, suchen wir für unser Schweizer Rare Disease Team eine engagierte und kundenorientierte Persönlichkeit für unseren Aussendienst.
In dieser Rolle betreuen Sie ein innovatives Portfolio in den Bereichen seltene Erkrankungen, Ophthalmologie und Neurologie sowie ausgewählte Biosimilars. Sie arbeiten mit unterschiedlichen Kundengruppen im Spital- und Praxisumfeld und tragen dazu bei, dass relevante medizinische Innovationen die richtigen Patientinnen und Patienten erreichen.
AUFGABENSTELLUNG:
IHR PROFIL:
WIR BIETEN IHNEN:
Wenn Sie Interesse haben, als Teil eines motivierten Teams mit innovativen Produkten Patientinnen und Patienten zu helfen, freuen wir uns auf Ihre Online-Bewerbung!
-----------------------------------------------------------------------------------------------------------------------------------
As a leading international biotechnology company with the mission to serve patients, we are looking for an engaged and customer-focused professional to join our Swiss Rare Disease field force.
In this role, you will manage an innovative portfolio in Rare Diseases, Ophthalmology and Neurology, as well as selected biosimilars. You will work with different customer groups across hospital and office-based settings and contribute to ensuring that relevant medical innovations reach the right patients.
YOUR RESPONSIBILITIES:
YOUR PROFILE:
WE OFFER YOU:
If you would like to join a motivated team and help patients through innovative products, we look forward to receiving your online application!
.Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen